VIVUS Reports Fourth Quarter and Year-End 2013 Financial Results

[GlobeNewswire] – MOUNTAIN VIEW, Calif. — VIVUS, Inc. , a biopharmaceutical company commercializing Qsymia(R) (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today provided a business … more

View todays social media effects on VVUS

View the latest stocks trending across Twitter. Click to view dashboard

See who VIVUS is hiring next, click here to view